Unbiased Analysis of Today's Healthcare Issues

NCCN Evidence Blocks

NCCN recently released a new approach to measure the value of cancer medicines. The approach–known as Evidence Blocks–evaluates medications on 5 dimensions: Efficacy of regimens, Safety of regimens, Quality and quantity of evidence for regimens, Consistency of evidence for regimens, and Affordability of regimens. Each criteria is ranked on a 1 to 5 block scale. […]

Read the rest of this entry »

Trends in Drug Approvals: 1987–2011

Many individuals have claimed that new drug approvals are declining over time.  A recent article by Lanthier et al. (2013) finds the following trends. Courtesy of Health Affairs. Drug approvals seem to be fairly steady over time, except for a decline in addition-to-class drugs. Why is this? The authors hypothesize as follows: Today we see […]

Read the rest of this entry »